Search Results - "CRIPE, Larry"

Predicting symptoms of anxiety and depression in patients living with advanced cancer: the differential roles of hope and optimism by Fischer, Ian C., Cripe, Larry D., Rand, Kevin L.

“…Purpose Psychological distress is related to poorer functioning and reduced quality of life in patients with advanced cancer and may have untoward influences…”
Get full text

Hope Is the Thing With Feathers by Cripe, Larry D

“…Cripe talks about the capacity to hope. Hopefulness is a fundamental human perspective that allows a person to imagine the future as possible and, to some…”
Get full text

Extramedullary Disease in Adult Acute Myeloid Leukemia Is Common but Lacks Independent Significance: Analysis of Patients in ECOG-ACRIN Cancer Research Group Trials, 1980-2008 by Ganzel, Chezi, Manola, Judith, Douer, Dan, Rowe, Jacob M, Fernandez, Hugo F, Paietta, Elisabeth M, Litzow, Mark R, Lee, Ju-Whei, Luger, Selina M, Lazarus, Hillard M, Cripe, Larry D, Wiernik, Peter H, Tallman, Martin S

“…Purpose Extramedullary disease (EMD) at diagnosis in patients with acute myeloid leukemia (AML) has been recognized for decades. Reported herein are results…”
Get full text

Very poor long‐term survival in past and more recent studies for relapsed AML patients: The ECOG‐ACRIN experience by Ganzel, Chezi, Sun, Zhuoxin, Cripe, Larry D., Fernandez, Hugo F., Douer, Dan, Rowe, Jacob M., Paietta, Elisabeth M., Ketterling, Rhett, O'Connell, Michael J., Wiernik, Peter H., Bennett, John M., Litzow, Mark R., Luger, Selina M., Lazarus, Hillard M., Tallman, Martin S.

“…This study examines the long‐term OS of relapsed AML patients who were enrolled to 9 successive ECOG‐ACRIN trials for newly diagnosed AML, during 1984‐2008…”
Get full text

Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia by Friedberg, Jonathan W., Sharman, Jeff, Sweetenham, John, Johnston, Patrick B., Vose, Julie M., LaCasce, Ann, Schaefer-Cutillo, Julia, De Vos, Sven, Sinha, Rajni, Leonard, John P., Cripe, Larry D., Gregory, Stephanie A., Sterba, Michael P., Lowe, Ann M., Levy, Ronald, Shipp, Margaret A.

“…Certain malignant B cells rely on B-cell receptor (BCR)–mediated survival signals. Spleen tyrosine kinase (Syk) initiates and amplifies the BCR signal. In in…”
Get full text

Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse by Levis, Mark, Ravandi, Farhad, Wang, Eunice S., Baer, Maria R., Perl, Alexander, Coutre, Steven, Erba, Harry, Stuart, Robert K., Baccarani, Michele, Cripe, Larry D., Tallman, Martin S., Meloni, Giovanna, Godley, Lucy A., Langston, Amelia A., Amadori, Sergio, Lewis, Ian D., Nagler, Arnon, Stone, Richard, Yee, Karen, Advani, Anjali, Douer, Dan, Wiktor-Jedrzejczak, W., Juliusson, Gunnar, Litzow, Mark R., Petersdorf, Stephen, Sanz, Miguel, Kantarjian, Hagop M., Sato, Takashi, Tremmel, Lothar, Bensen-Kennedy, Debra M., Small, Donald, Smith, B. Douglas

“…In a randomized trial of therapy for FMS-like tyrosine kinase-3 (FLT3) mutant acute myeloid leukemia in first relapse, 224 patients received chemotherapy alone…”
Get full text

Targeted detection and quantitation of histone modifications from 1,000 cells by Abshiru, Nebiyu A, Sikora, Jacek W, Camarillo, Jeannie M, Morris, Juliette A, Compton, Philip D, Lee, Tak, Neelamraju, Yaseswini, Haddox, Samuel, Sheridan, Caroline, Carroll, Martin, Cripe, Larry D, Tallman, Martin S, Paietta, Elisabeth M, Melnick, Ari M, Thomas, Paul M, Garrett-Bakelman, Francine E, Kelleher, Neil L

“…Histone post-translational modifications (PTMs) create a powerful regulatory mechanism for maintaining chromosomal integrity in cells. Histone acetylation and…”
Get full text

Goals of care communication and higher-value care for patients with advanced-stage cancer: A systematic review of the evidence by Cripe, Larry D., Vater, Laura B., Lilly, Jason A., Larimer, Angeline, Hoffmann, Mary Lynn, Frankel, Richard M.

“…•We couldn’t derive a consensus definition of GOC communication topics, behaviors, timing, or anticipated outcomes.•Goals were most commonly descriptions of…”
Get full text

We were in the fight together: The expectations of bereaved caregivers of patients with acute myeloid leukemia from diagnosis to death by Cottingham, Ann H., Baker, Layla B., Hoffmann, Mary Lynn, Martin, Caroline E., Cripe, Larry D.

“…Patients with hematologic malignancies are more optimistic than their oncologists and their expectations may be a barrier to timely hospice care. Patient…”
Get full text

Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999 by Cripe, Larry D., Uno, Hajime, Paietta, Elisabeth M., Litzow, Mark R., Ketterling, Rhett P., Bennett, John M., Rowe, Jacob M., Lazarus, Hillard M., Luger, Selina, Tallman, Martin S.

“…Zosuquidar, which modulates P-glycoprotein (P-gp) with minimal delay of anthracycline clearance, may reverse P-gp–mediated resistance in acute myeloid leukemia…”
Get full text

The Goal Inventory: An Innovative Digital Resource to Help Patients Identify and Evaluate Their Goals by Cripe, Larry D., Cottingham, Ann H., Monahan, Patrick O., Stump, Timothy E., Shuler, Miranda G., Comer, Robert S., Martin, Caroline E., Uhrich, Margaret M., Gilmore, Alexis

Get full text

Music Therapy Is Associated With Family Perception of More Spiritual Support and Decreased Breathing Problems in Cancer Patients Receiving Hospice Care by Burns, Debra S., PhD, MT-BC, Perkins, Susan M., PhD, Tong, Yan, MS, Hilliard, Russell E., PhD, LCSW, MT-BC, Cripe, Larry D., MD

“…Abstract Context Music therapy is a common discretionary service offered within hospice; however, there are critical gaps in understanding the effects of music…”
Get full text

Obesity in adult acute myeloid leukemia is not associated with inferior response or survival even when dose capping anthracyclines: An ECOG‐ACRIN analysis by Foran, James M., Sun, Zhuoxin, Lai, Catherine, Fernandez, Hugo F., Cripe, Larry D., Ketterling, Rhett P., Racevskis, Janis, Luger, Selina M., Paietta, Elisabeth, Lazarus, Hillard M., Zhang, Yanming, Bennett, John M., Levine, Ross L., Rowe, Jacob M., Litzow, Mark R., Tallman, Martin S.

“…Background Obesity (body mass index [BMI] ≥30 kg/m2) is an important epidemiological risk factor for developing acute myeloid leukemia (AML). Therefore, the…”
Get full text

Life and treatment goals of patients with advanced, incurable cancer by Rand, Kevin L., Banno, Daniella A., Shea, Amanda M., Cripe, Larry D.

“…Purpose Goals of care conversations have been suggested as a strategy for helping patients with advanced cancer manage the uncertainty and distress associated…”
Get full text

Prognostic effect of gender on outcome of treatment for adults with acute myeloid leukaemia by Wiernik, Peter H., Sun, Zhuoxin, Cripe, Larry D., Rowe, Jacob M., Fernandez, Hugo F., Luger, Selina M., Lazarus, Hillard M., Paietta, Elisabeth M., Tallman, Martin S., Litzow, Mark R.

“…Summary There are conflicting reports in the literature suggesting that one gender or the other has a better survival with acute myeloid leukaemia (AML). The…”
Get full text

Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS by Barreyro, Laura, Will, Britta, Bartholdy, Boris, Zhou, Li, Todorova, Tihomira I., Stanley, Robert F., Ben-Neriah, Susana, Montagna, Cristina, Parekh, Samir, Pellagatti, Andrea, Boultwood, Jacqueline, Paietta, Elisabeth, Ketterling, Rhett P., Cripe, Larry, Fernandez, Hugo F., Greenberg, Peter L., Tallman, Martin S., Steidl, Christian, Mitsiades, Constantine S., Verma, Amit, Steidl, Ulrich

“…Cellular and interpatient heterogeneity and the involvement of different stem and progenitor compartments in leukemogenesis are challenges for the…”
Get full text

Evidence of a role for functional heterogeneity in multidrug resistance transporters in clinical trials of P‐glycoprotein modulation in acute myeloid leukemia by Marcelletti, John F., Sikic, Branimir I., Cripe, Larry D., Paietta, Elisabeth

“…Background Multidrug resistance (MDR) transporter proteins such as P‐glycoprotein (P‐gp) efflux a variety of chemotherapeutic drugs from acute myeloid leukemia…”
Get full text

Combination of sorafenib, vorinostat and bortezomib for the treatment of poor-risk AML: report of two consecutive clinical trials by Sayar, Hamid, Cripe, Larry D., Saliba, Antoine N., Abu Zaid, Mohammad, Konig, Heiko, Boswell, H. Scott

Get full text

Lenalidomide and prednisone for myelofibrosis: Eastern Cooperative Oncology Group (ECOG) phase 2 trial E4903 by Mesa, Ruben A., Yao, Xiaopan, Cripe, Larry D., Li, Chin Yang, Litzow, Mark, Paietta, Elisabeth, Rowe, Jacob M., Tefferi, Ayalew, Tallman, Martin S.

“…A multicenter Eastern Cooperative Group (ECOG) phase 2 trial assessed whether adding prednisone to lenalidomide would improve previously reported responses in…”
Get full text

Trustworthiness by Cripe, Larry D

Get full text